Ana I. Velázquez Mañana: Dr Oscar Arrieta highlights efforts to increase cancer research and cancer care delivery in Mexico and LATAM

Ana I. Velázquez Mañana shared a post on X:

“Dr Oscar Arrieta highlights efforts to increase cancer research & cancer care delivery in Mexico and LATAM. Lung Cancer is a global disease and similarly our treatments, diagnostics, and supportive care should also be.”

Source: Ana I. Velázquez Mañana/X

Dr. Oscar Arrieta is strongly dedicated to clinical and translational research in the field of Thoracic Oncology. Since 2005, he has been head of the Thoracic Oncology Unit and Laboratory of Personalized Medicine at the National Institute of Cancer in México City (INCan). Additionally, Dr. Arrieta is a faculty member of the National Autonomous University of México (UNAM), with more than 25 years of experience. Currently, he is a Medical Oncology and Thoracic Oncology professor

Ana Velázquez Mañana is an Assistant Professor of Medicine in the UCSF Division of Hematology/Oncology at Zuckerberg San Francisco General and a thoracic oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center. She serves as Assistant Director of Diversity, Equity, Inclusion, and Accessibility for Trainees of the UCSF Helen Diller Family Comprehensive Cancer Center and co-chairs the UCSF Department of Medicine Fellowship Diversity Committee. Her research, advocacy, and education efforts are focused on promoting and advancing health equity and workforce diversity.